SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Évolutions technologiques en qualification biologique du don et leur impact sur le risque résiduel transfusionnel
14 references·0 citing·36 second hop
Évolutions technologiques en qualification biologique du don et leur impact sur le risque résiduel transfusionnel (2011)Évolutions technologiques en qualificatio…Hepatitis B, hepatitis C and HIV transfusion‐transmitted infections in the 21st century (2010)Hepatitis B, hepatitis C and …Estimation quantitative du risque de contamination d’un don de sang par des agents infectieux (2009)Estimation quantitative du ri…Transfusion‐transmitted human immunodeficiency virus infection by a Danish blood donor with a very low viral load in the preseroconversion window phase (2008)Transfusion‐transmitted human…Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 201 (2008)Comparison of the analytical …Multicenter performance evaluation of a transcription‐mediated amplification assay for screening of human immunodeficiency virus‐1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations (2005)Multicenter performance evalu…Differential transmission of human immunodeficiency virus (HIV) via blood components from an HIV‐infected donor (2005)Differential transmission of …Window‐period human immunodeficiency virus transmission to two recipients by an adolescent blood donor (2004)Window‐period human immunodef…Triggers for switching from minipool testing by nucleic acid technology to individual‐donation nucleic acid testing for West Nile virus: Analysis of 2003 data to inform 2004 decision making (2004)Triggers for switching from m…Risque résiduel de transmission du VIH, du VHC et du VHB par transfusion sanguine entre 1992 et 2002 en France et impact du dépistage génomique viral (2004)Risque résiduel de transmissi…First report of human immunodeficiency virus transmission via an RNA‐screened blood donation (2004)First report of human immunod…Failure and success of HIV tests for the prevention of HIV‐1 transmission by blood and tissue donations (2004)Failure and success of HIV te…Application de la biologie moléculaire à la sécurité virale transfusionnelle : le dépistage génomique viral (2003)Application de la biologie mo…Trends in residual risk of transfusion‐transmitted viral infections in France between 1992 and 2000 (2002)Trends in residual risk of tr…The Risk of Transfusion-Transmitted Viral Infections (1996)The Risk of Transfusion-Trans…The Cambridge Ancient History (1971)International application of the Incidence Rate/Window Period model (2002)Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA (2006)Evaluation of a multiplex human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand (2007)Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT) (2005)Blood donor screening with cobas s 201/cobas TaqScreen MPX under routine conditions at German Red Cross institutes (2009)One‐year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations (2009)Evaluation of two, commercial, multi‐dye, nucleic acid amplification technology tests, for HBV/HCV/HIV‐1/HIV‐2 and B19V/HAV, for screening blood and plasma for further manufacture (2012)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Residual infectious disease risk in screened blood transfusion from a high‐prevalence population: Santa Catarina, Brazil (2007)Risque résiduel de transmission du VIH et du VHB par transfusion sanguine entre 2003 et 2005 au Centre national de transfusion sanguine de Dakar (Sénégal) (2009)The risk of transfusion-transmitted viral infections at the Gabonese National Blood Transfusion Centre. (2014)Failure of Routine HIV-1 Tests in a Case Involving Transmission With Preseroconversion Blood Components During the Infectious Window Period (2000)NAT of the United States and Canadian blood supply (2000)Transfusion Safety: Where Are We Today? (2005)HIV Transmission Through Transfusion—Missouri and Colorado, 2008 (2011)History and Future of Nucleic Acid Amplification Technology Blood Donor Testing (2019)10.1016/s0000-0000(03)47688-2 (2000)Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing (2005)Residual risk of transfusion‐transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy (2005)Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States (1995)Current Safety of the Blood Supply in the United States (2004)Trends in prevalence, incidence, and residual risk of major transfusion‐transmissible viral infections in United Arab Emirates blood donors: impact of individual‐donation nucleic acid testing, 2004 through 2009 (2012)Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV‐1 antibody screening (1991)Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion (2009)Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing (2010)Multinational assessment of blood‐borne virus testing and transfusion safety on the African continent (2012)The prevalence of transfusion-transmitted infections and nucleic acid testing among blood donors in Majmaah, Saudi Arabia (2018)Factors in enhancing blood safety by nucleic acid technology testing for human immunodeficiency virus, hepatitis C virus and hepatitis B virus (2014)A study of centralized individual donor nucleic acid testing for transfusion transmitted infections to improve blood safety in Karnataka, India (2017)Transfusion of HIV‐infected blood products despite highly sensitive nucleic acid testing (2019)The Development of West Nile Virus Safety Policies by Canadian Blood Services: Guiding Principles and a Comparison Between Canada and the United States (2006)A modeling framework for evaluation and comparison of trigger strategies for switching from minipool to individual‐donation testing for West Nile virus (2009)Health economics of blood transfusion safety – focus on sub-Saharan Africa (2009)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)
this work references cited by second hop

References

  • 1996The Risk of Transfusion-Transmitted Viral Infections1,865 cited
  • 2010Hepatitis B, hepatitis C and HIV transfusion‐transmitted infections in the 21st century144 cited
  • 2004First report of human immunodeficiency virus transmission via an RNA‐screened blood donation98 cited
  • 2002Trends in residual risk of transfusion‐transmitted viral infections in France between 1992 and 200098 cited
  • 2004Window‐period human immunodeficiency virus transmission to two recipients by an adolescent blood donor73 cited
  • 2004Risque résiduel de transmission du VIH, du VHC et du VHB par transfusion sanguine entre 1992 et 2002 en France et impact du dépistage génomique viral66 cited
  • 2004Triggers for switching from minipool testing by nucleic acid technology to individual‐donation nucleic acid testing for West Nile virus: Analysis of 2003 data to inform 2004 decision making63 cited
  • 2005Multicenter performance evaluation of a transcription‐mediated amplification assay for screening of human immunodeficiency virus‐1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations56 cited
  • 2008Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 20152 cited
  • 2004Failure and success of HIV tests for the prevention of HIV‐1 transmission by blood and tissue donations29 cited
  • 2003Application de la biologie moléculaire à la sécurité virale transfusionnelle : le dépistage génomique viral29 cited
  • 2005Differential transmission of human immunodeficiency virus (HIV) via blood components from an HIV‐infected donor

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

25 cited
  • 2009Estimation quantitative du risque de contamination d’un don de sang par des agents infectieux24 cited
  • 2008Transfusion‐transmitted human immunodeficiency virus infection by a Danish blood donor with a very low viral load in the preseroconversion window phase12 cited
  • Cited by

    No citing works inside the corpus for this window.